drugset / Trial / NCT01008943
Autologous Cell Therapy for Female Stress Urinary Incontinence
NaSingle-groupOpen-labelTreatment
Summary
The Autologous Cell Therapy for Female SUI study is a clinical trial to determine the safety and potential effectiveness of a single dose of 200 million Cook MyoSite Autologous Muscle Derived Cells for treatment of Stress Urinary Incontinence.
Timeline
- Start
- 2010-06-02
- Primary completion
- 2012-09-21
- Completion
- 2012-09-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Muscle Derived Cells | Cell therapy | 2e+08 cells | Other |